198 related articles for article (PubMed ID: 16845513)
1. Non-specific binding of [18F]FDG to calcifications in atherosclerotic plaques: experimental study of mouse and human arteries.
Laitinen I; Marjamäki P; Haaparanta M; Savisto N; Laine VJ; Soini SL; Wilson I; Leppänen P; Ylä-Herttuala S; Roivainen A; Knuuti J
Eur J Nucl Med Mol Imaging; 2006 Dec; 33(12):1461-7. PubMed ID: 16845513
[TBL] [Abstract][Full Text] [Related]
2. Effects of age, diet, and type 2 diabetes on the development and FDG uptake of atherosclerotic plaques.
Silvola JM; Saraste A; Laitinen I; Savisto N; Laine VJ; Heinonen SE; Ylä-Herttuala S; Saukko P; Nuutila P; Roivainen A; Knuuti J
JACC Cardiovasc Imaging; 2011 Dec; 4(12):1294-301. PubMed ID: 22172786
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of alphavbeta3 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice.
Laitinen I; Saraste A; Weidl E; Poethko T; Weber AW; Nekolla SG; Leppänen P; Ylä-Herttuala S; Hölzlwimmer G; Walch A; Esposito I; Wester HJ; Knuuti J; Schwaiger M
Circ Cardiovasc Imaging; 2009 Jul; 2(4):331-8. PubMed ID: 19808614
[TBL] [Abstract][Full Text] [Related]
4. Uptake of inflammatory cell marker [11C]PK11195 into mouse atherosclerotic plaques.
Laitinen I; Marjamäki P; Någren K; Laine VJ; Wilson I; Leppänen P; Ylä-Herttuala S; Roivainen A; Knuuti J
Eur J Nucl Med Mol Imaging; 2009 Jan; 36(1):73-80. PubMed ID: 18712383
[TBL] [Abstract][Full Text] [Related]
5. [18F]fluorodeoxyglucose uptake in atherosclerotic plaques is associated with reduced coronary flow reserve in mice.
Uotila S; Silvola JM; Saukko P; Nuutila P; Heinonen SE; Ylä-Herttuala S; Roivainen A; Knuuti J; Saraste A
J Ultrasound Med; 2014 Nov; 33(11):1941-8. PubMed ID: 25336481
[TBL] [Abstract][Full Text] [Related]
6. Should vascular wall
Lensen KDF; Voskuyl AE; Comans EFI; van der Laken CJ; Boellaard R; Smulders YM
Int J Cardiovasc Imaging; 2020 Mar; 36(3):545-551. PubMed ID: 31898005
[TBL] [Abstract][Full Text] [Related]
7. Detection of hypoxia by [18F]EF5 in atherosclerotic plaques in mice.
Silvola JM; Saraste A; Forsback S; Laine VJ; Saukko P; Heinonen SE; Ylä-Herttuala S; Roivainen A; Knuuti J
Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1011-5. PubMed ID: 21372297
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of 18F-FDG uptake and arterial wall calcifications using 18F-FDG PET/CT.
Ben-Haim S; Kupzov E; Tamir A; Israel O
J Nucl Med; 2004 Nov; 45(11):1816-21. PubMed ID: 15534049
[TBL] [Abstract][Full Text] [Related]
9. Type 2 diabetes enhances arterial uptake of choline in atherosclerotic mice: an imaging study with positron emission tomography tracer ¹⁸F-fluoromethylcholine.
Hellberg S; Silvola JM; Kiugel M; Liljenbäck H; Metsälä O; Viljanen T; Metso J; Jauhiainen M; Saukko P; Nuutila P; Ylä-Herttuala S; Knuuti J; Roivainen A; Saraste A
Cardiovasc Diabetol; 2016 Feb; 15():26. PubMed ID: 26852231
[TBL] [Abstract][Full Text] [Related]
10. Exploiting Glutamine Consumption in Atherosclerotic Lesions by Positron Emission Tomography Tracer (2
Palani S; Miner MWG; Virta J; Liljenbäck H; Eskola O; Örd T; Ravindran A; Kaikkonen MU; Knuuti J; Li XG; Saraste A; Roivainen A
Front Immunol; 2022; 13():821423. PubMed ID: 35145523
[TBL] [Abstract][Full Text] [Related]
11. [18F]FDG Accumulation in Early Coronary Atherosclerotic Lesions in Pigs.
Tarkia M; Saraste A; Stark C; Vähäsilta T; Savunen T; Strandberg M; Saunavaara V; Tolvanen T; Teuho J; Teräs M; Metsälä O; Rinne P; Heinonen I; Savisto N; Pietilä M; Saukko P; Roivainen A; Knuuti J
PLoS One; 2015; 10(6):e0131332. PubMed ID: 26120829
[TBL] [Abstract][Full Text] [Related]
12. Correlation of inflammation assessed by 18F-FDG PET, active mineral deposition assessed by 18F-fluoride PET, and vascular calcification in atherosclerotic plaque: a dual-tracer PET/CT study.
Derlin T; Tóth Z; Papp L; Wisotzki C; Apostolova I; Habermann CR; Mester J; Klutmann S
J Nucl Med; 2011 Jul; 52(7):1020-7. PubMed ID: 21680686
[TBL] [Abstract][Full Text] [Related]
13. Uptake of 11C-choline in mouse atherosclerotic plaques.
Laitinen IE; Luoto P; Någren K; Marjamäki PM; Silvola JM; Hellberg S; Laine VJ; Ylä-Herttuala S; Knuuti J; Roivainen A
J Nucl Med; 2010 May; 51(5):798-802. PubMed ID: 20395326
[TBL] [Abstract][Full Text] [Related]
14. Comparison of atorvastatin 5 and 20 mg/d for reducing F-18 fluorodeoxyglucose uptake in atherosclerotic plaques on positron emission tomography/computed tomography: a randomized, investigator-blinded, open-label, 6-month study in Japanese adults scheduled for percutaneous coronary intervention.
Ishii H; Nishio M; Takahashi H; Aoyama T; Tanaka M; Toriyama T; Tamaki T; Yoshikawa D; Hayashi M; Amano T; Matsubara T; Murohara T
Clin Ther; 2010 Dec; 32(14):2337-47. PubMed ID: 21353104
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography.
Tawakol A; Migrino RQ; Hoffmann U; Abbara S; Houser S; Gewirtz H; Muller JE; Brady TJ; Fischman AJ
J Nucl Cardiol; 2005; 12(3):294-301. PubMed ID: 15944534
[TBL] [Abstract][Full Text] [Related]
16. Gene expression and 18FDG uptake in atherosclerotic carotid plaques.
Pedersen SF; Graebe M; Fisker Hag AM; Højgaard L; Sillesen H; Kjaer A
Nucl Med Commun; 2010 May; 31(5):423-9. PubMed ID: 20145577
[TBL] [Abstract][Full Text] [Related]
17. Positron Emission Tomography Imaging of Macrophages in Atherosclerosis with
Hellberg S; Liljenbäck H; Eskola O; Morisson-Iveson V; Morrison M; Trigg W; Saukko P; Ylä-Herttuala S; Knuuti J; Saraste A; Roivainen A
Contrast Media Mol Imaging; 2018; 2018():9186902. PubMed ID: 29950954
[TBL] [Abstract][Full Text] [Related]
18. 18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease.
Rominger A; Saam T; Wolpers S; Cyran CC; Schmidt M; Foerster S; Nikolaou K; Reiser MF; Bartenstein P; Hacker M
J Nucl Med; 2009 Oct; 50(10):1611-20. PubMed ID: 19759117
[TBL] [Abstract][Full Text] [Related]
19. 18-kDa translocator protein ligand
Hellberg S; Silvola JMU; Kiugel M; Liljenbäck H; Savisto N; Li XG; Thiele A; Lehmann L; Heinrich T; Vollmer S; Hakovirta H; Laine VJO; Ylä-Herttuala S; Knuuti J; Roivainen A; Saraste A
J Nucl Cardiol; 2017 Jun; 24(3):862-871. PubMed ID: 27225517
[TBL] [Abstract][Full Text] [Related]
20. Quantification of inflammation within rabbit atherosclerotic plaques using the macrophage-specific CT contrast agent N1177: a comparison with 18F-FDG PET/CT and histology.
Hyafil F; Cornily JC; Rudd JH; Machac J; Feldman LJ; Fayad ZA
J Nucl Med; 2009 Jun; 50(6):959-65. PubMed ID: 19443582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
